4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-043843
Chief Financial Officer sold 1,693 shares at $11.80 ($19,977)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2023-07-28 | Sale | −1,693 | $11.80 | $19,977 | 146,136 | D |
| Open-market sales · 1,693 sh · avg $11.80 · $19,977 | |||||||
Loading xslF345X05/doc4.xml…